ClinicalTrials.gg
RecruitingNCT07794930Updated Nov 18, 2026

Integrating Values Based Communication in Heart Failure Management

An interventional study of Serious Illness Care Program for Heart Failure (SICP-HF) in Heart Failure, sponsored by Abigail Latimer. Recruiting at 1 site in United States. Open to participants aged 18 Years to 105 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Abigail Latimer · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 18, 2026Now RecruitingSite recruiting status changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
18 Years to 105 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 2,159 studies in Heart Failure with a site in United States — 347 open to participants now, 439 under way, 27 of them phase 3. Heart Failure · United States.

Planned enrollment
458th of 1,602
200 · median 66
Started
2026
with 94 others
No phase
887 of 2,159
160 open now
Primary completion
2028-12
later than 343 of 438 live
Registered
2,142nd of 2,159
by date

Among the 2,159 studies in Heart Failure with a site in United States, this one is the 458th largest by planned enrollment of the 1,602 interventional ones that give a count, is one of 95 that started in 2026, is one of 887 with no phase, reaches primary completion later than 343 of the 438 other live ones, and was the 2,142nd registered.

Heart Failure

6,339 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

347 of the 2,159 studies in Heart Failure with a site in United States are open now. Recruiting first, the newest first:

341 more — sign in →

All 347 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 89 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 18 Years to 105 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,159 studies in Heart Failure with a site in United States, or all of them as a file.
02

Study summary

Living with heart failure for adults over age 50 is hard. Older adults have to take many medicines to address heart failure and other health problems. That group of individuals must decide which medications to take and which devices to use to support heart health. Doctors, nurses, and social workers help patients understand these options but do not always know what is most important to them. Talking with patients about what the patients are hoping for, what the patients are worried about, and how much the patients understand about the illness is called a serious illness conversation, and it is hard to do. Doctors, nurses, and social workers are very busy and worry about upsetting patients by bringing up hard topics.

The Serious Illness Care Program helps doctors, nurses, and social workers have these conversations by giving the staff a script to follow on what to say. The program also includes ways to make sure staff remember to have the conversation, a brief training, and how to document what is said during the conversation. But, nobody has studied the Serious Illness Care Program in a heart failure clinic, so it has not been customized to meet the needs of heart failure teams or older adults with heart failure.

Many programs that are supposed to help patients fail in the real world. One reason is that patients do not include the needs of those who will receive and deliver it. Before this project, the team interviewed heart failure doctors, nurses, social workers, and other staff at a heart failure clinic. As well as interviewing older adults and care partners. The team asked staff how the Serious Illness Care Program can be changed to fit the needs and work in the clinic. The program includes a conversation guide that helps the team know what to say, so the study team asked patients and care partners what the thoughts on the language used and the topics covered. Then, the team practiced putting the program in place at the clinic and trained clinicians on using the Serious Illness Care Program with older adults and family members.

Now the team wants to see if the heart failure team likes it and if it is doable. The team will also ask patients and care partners about the conversation and about feelings of anxiety before, during, and after the conversation. Lastly, the team will ask the individuals before and after the conversation about patients' knowledge of heart failure and how prepared the care partner feels to care for the individual. The team also want to explore how the program helps clinicians understand patients' symptoms, quality of life, and illness knowledge.

Ultimately, this project establishes a structured framework to facilitate goals-of-care discussions between heart failure teams, patients, and families. These conversations empower patients to make immediate and future medical decisions aligned with personal values and lifestyle preferences. This values-based decision-making process optimizes care delivery and supports patients in achieving optimal health outcomes.

Read the detailed description

During this trial, the team aims to enroll three separate groups of participants: patients, care partners, and clinicians. Care partners are not required to participate with patients, but may choose to. At participating sites, trained clinician participants will identify patients through standard workflows, and research assistants will also screen clinic schedules for potentially eligible patients. If appropriate and eligible, the clinician will contact patients to gauge interest in participating in the study. Patients will receive information by mail before the clinic visit where the intervention, the Serious Illness Conversation, will occur. The mailing will include a handout that prompts the patient to think about and pre-answer many of the questions the clinician may cover during the visit. Patients will consent and complete enrollment measures before the clinic visit. Patients may complete these measures via an electronic link or paper format. Follow-up links or paper versions of measures will be provided following the visit at the 24-48 hour mark, 1 month, and 3 months.

03

Conditions studied

  • Heart Failure

Browse trials for

04

Who can participate

Ages eligible
18 Years to 105 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adult patients with a diagnosis of heart failure.
  • Care partners providing support to an enrolled patient.
  • Heart failure clinic staff participating in implementation of the intervention.
  • Able to provide .
  • English speaking.

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment affecting the ability to provide or follow study procedures.
  • Major psychiatric disorders that interfere with participation.
  • Non-English speaking.
  • Clinic staff who do not work in the heart failure clinic.
  • Students are not eligible to participate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Serious Illness Care Program for Heart Failure (SICP-HF)

    Participants receive the Serious Illness Care Program adapted for heart failure (SICP-HF). Clinicians are trained to integrate the communication intervention into routine outpatient heart failure care. Patients, care partners, and clinic staff participate in implementation and evaluation activities.

    Behavioral: Serious Illness Care Program for Heart Failure (SICP-HF)

Interventions

  • BehavioralSerious Illness Care Program for Heart Failure (SICP-HF)

    The Serious Illness Care Program adapted for heart failure is a behavioral communication intervention that includes clinician training and use of a structured Serious Illness Conversation Guide to facilitate values-based communication during the routine heart failure care. The intervention is implemented in an outpatient cardiology clinic and evaluated using a pre-post design.

06

What researchers measure

Primary outcomes

  1. The Survey of Illness Beliefs in Heart Failure

    Survey of Illness Beliefs in Heart Failure: 14-item measure of the accuracy of patients' beliefs about heart failure. Items are rated on a 4-point Likert scale from 1 (strongly disagree) to 4 (strongly agree). Responses are scored to reflect accurate versus inaccurate illness beliefs, producing a total score ranging from 0 to 14. Higher scores indicate more accurate illness beliefs (better outcome).

    Time frame: At enrollment, then at 1 month and 3 months post intervention

Secondary outcomes

  1. Anxiety

    We will be using the State-Trait Anxiety Inventory (STAI), which is a 40-item self-report psychological test measuring two distinct types of anxiety: temporary, situation-based "state anxiety" and long-standing, baseline "trait anxiety". Administered to patient participants only. State anxiety (20 items) and trait anxiety (20 items) are subscales. Each subscale is scored from 20 to 80, with higher scores indicating greater anxiety (worse outcome).

    Time frame: Trait anxiety will be measured at enrollment and at 1month and 3 months post-intervention. State anxiety will be measured 24-48 hours prior to intervention and again 24-48 hours post intervention.

  2. Caregiver Preparedness

    Preparedness for Caregiving Scale: 8-item measure assessing caregivers' perceived preparedness to provide care and manage caregiving-related tasks. Items are rated on a 5-point scale from 0 (not at all prepared) to 4 (very well prepared), with total scores ranging from 0 to 32. Higher scores indicate greater caregiver preparedness (better outcome).

    Time frame: This survey will be administered at enrollment, then again at 1 month and 3 months post-intervention.

Other outcomes

  1. Kansas City Cardiomyopathy Questionnaire (KCQQ-12)

    The KCCQ-12 is a survey for people with heart failure measuring physical limits, symptoms, quality of life, and social restrictions. 12-item patient-reported measure of health status in heart failure, including symptoms, physical limitations, social limitations, quality of life, and symptom stability. Scores are transformed to a 0-100 scale, with 0 representing the worst health status and 100 representing the best health status. Higher scores indicate better heart failure-related health status (better outcome).

    Time frame: At enrollment and 1 month and 3 months post intervention.

  2. Clinician-Patient Concordance in New York Heart Association Functional Class

    Concordance between the clinician's assessment of the patient's current New York Heart Association (NYHA) functional class (Class I-IV) and the patient's heart failure health status as assessed using the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12). Clinician responses will be categorized as concordant, discordant, or intermediate based on prespecified mapping of KCCQ-12 responses to NYHA functional class. Lower discordance indicates better clinician-patient assessment agreement.

    Time frame: Immediately following the clinician encounter

  3. Quality of Communication

    CollaboRATE: 3-item patient-reported measure of the quality of shared decision-making during a healthcare encounter. Each item is scored from 0 (no effort was made) to 9 (every effort was made). The total score ranges from 0 to 27, with higher scores indicating greater perceived shared decision-making (better outcome).

    Time frame: One time 24-48 hours post-intervention.

  4. Clinician-Patient Concordance in Quality of Life

    Concordance between the clinician's assessment of the patient's current overall quality of life (excellent, very good, good, fair, or poor) and the patient's quality of life as assessed using the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12). Clinician responses will be categorized as concordant, discordant, or intermediate based on prespecified mapping of KCCQ-12 responses. Higher concordance indicates better clinician-patient assessment agreement.

    Time frame: Immediately following the clinician encounter

  5. Clinician-Patient Concordance in Heart Failure Symptom Frequency

    Concordance between the clinician's assessment of the frequency of the patient's current heart failure symptoms (never, rarely, sometimes, often, or almost always) and the patient's symptom burden as assessed using the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12). Clinician responses will be categorized as concordant, discordant, or intermediate based on prespecified mapping of KCCQ-12 responses. Higher concordance indicates better clinician-patient assessment agreement.

    Time frame: Immediately following the clinician encounter

  6. Clinician-Patient Concordance in Expected Health Status Trajectory

    Concordance between the clinician's anticipated patient health status trajectory over the next 6-12 months (significant improvement, some improvement, approximately the same, some decline, significant decline, or uncertain) and the patient's current health status as assessed using the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12). Clinician responses will be categorized as concordant, discordant, or intermediate based on prespecified mapping of KCCQ-12 responses. Higher concordance indicates better clinician-patient assessment agreement.

    Time frame: Immediately following the clinician encounter

  7. Clinician-Patient Concordance in Primary Factor Impacting Quality of Life

    Concordance between the clinician's identification of the primary factor currently impacting the patient's quality of life (heart failure symptoms, other medical conditions/comorbidities, physical functioning or limitations, emotional/psychological concerns, social or family circumstances, financial or housing concerns, treatment burden/healthcare demands, other, or unable to assess) and the patient's reported health status and quality-of-life responses on the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12). Responses will be categorized as concordant, discordant, or intermediate according to prespecified mapping. Higher concordance indicates better clinician-patient assessment agreement.

    Time frame: Immediately following the clinician encounter

07

Study locations

1 of 1 sites recruiting
  • Norton Heart & Vascular Institute - Advanced Heart Failure & Recovery Program
    Louisville, Kentucky 40241, United States
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2028, 26 months after the start.

Of 1,118 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 26 months is below that.

Counting every sponsor, half of 1,354 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2026
First posted
Aug 31, 2026
StartActual
Oct 1, 2026
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
Norton Heart & Vascular Institute - Advanced Heart Failure & Recovery Program is now Recruiting
Nov 18, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Norton Heart & Vascular Institute - Advanced Heart Failure & Recovery Program · Louisville, United StatesContact added k•••@nortonhealthcare.org
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Norton Heart & Vascular Institute - Advanced Heart Failure & Recovery Program is now Recruiting
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Norton Heart & Vascular Institute - Advanced Heart Failure & Recovery Program · Louisville, United StatesContact added k•••@nortonhealthcare.org
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07794930
Lead sponsor
Abigail Latimer
Collaborators
American Heart Association
Responsible party
Abigail Latimer (Assistant Professor, University of Kentucky) — Sponsor-investigator
First posted
Aug 31, 2026
Start date
Oct 1, 2026
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Abigail Latimer
Contact
abbie.latimer@uky.edu
8592571267

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion